Safety and efficacy of sildenafil citrate in the treatment of Parkinson-emergent erectile dysfunction: a double-blind, placebo-controlled, randomized study

@article{Safarinejad2010SafetyAE,
  title={Safety and efficacy of sildenafil citrate in the treatment of Parkinson-emergent erectile dysfunction: a double-blind, placebo-controlled, randomized study},
  author={Mohammah Reza Safarinejad and Arsia Taghva and Babak Shekarchi and Sh Safarinejad},
  journal={International Journal of Impotence Research},
  year={2010},
  volume={22},
  pages={325-335}
}
Parkinson's disease (PD) is one of the most commonly occurring neurodegenerative disorders, with lifetime incidence between 1 and 2% among people older than 65 years. ED is one of the more disabling and poorly addressed aspects of PD. The purpose of this study was to assess the efficacy and safety of sildenafil citrate in Parkinson-emergent ED. Sexual function of participants was assessed using responses to the 15-question International Index of Erectile Function (IIEF), Sexual Encounter… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 32 references

Similar Papers

Loading similar papers…